Pediatric Use
BreathTek UBT is approved for use in children ages 3 to 17 years
Guidelines recommend against using antibody-based serology tests.1
It is recommended that one of following tests be used to determine whether H. pylori treatment was successful: (1) The 13C-UBT or (2) a 2 step monoclonal stool antigen test.
Confirming eradication is important because of:
- Poor adherence with medications2
- Reinfection due to intrafamilial transmission2
- Increasing antibiotic resistance1
- In children treated with standard H. pylori therapy, eradication rates have been decreasing over time, in part because of increased antibiotic resistance1
- Data suggest high rates of H. pylori antibiotic resistance in some pediatric populations1,3